Claims for Patent: 8,765,471

Summary for Patent: 8,765,471

Title:	Neutral protease (NP) and product by using neutral protease for tissue dissociation as well as method for the production thereof
Abstract:	The use of a neutral protease (NP) together with a collagenase consists in that a neutral protease which is not contained in a collagenase enzyme preparation and which is not produced by a recombinant production is mixed before the beginning of a tissue dissociation with a collagenase or a collagenase enzyme preparation with an individual dosage of the quantitative proportions of neutral protease and collagenase for improving the isolation results with respect to yield, viability and integrity of the cells.
Inventor(s):	Kurfuerst; Manfred (Moorrege, DE), Raemsch; Christian (Uetersen, DE), Raemsch-Guenther; Nicole (Uetersen, DE), Friedrich; Olaf (Tornesch, DE), Huettler; Silke (Uetersen, DE), Brandhorst; Daniel (Linden, DE), Berney; Thierry (Arenthon, FR), Bucher; Pascal (Geneva, CH), Brandhorst; Heide (Linden, DE)
Assignee:	Nordmark Arzneimittel GmbH & Co. KG (Uetersen, DE)
Application Number:	13/862,773
Patent Claims:	1. A method for isolation of islets of Langerhans from a pancreatic tissue, comprising: mixing a separately prepared A component with a separately prepared B component in a predetermined mixing ratio of component A to component B to provide a reactant mixture, wherein the A component is a completely purified neutral protease (NP) from Clostridium histolyticum which is not contained in a collagenase enzyme preparation and which is not produced by a recombinant production, and the B component is a purified or partially purified collagenase; combining the reactant mixture directly thereafter with the pancreatic tissue; and isolating the islets of Langerhans. 2. The method of claim 1, wherein the mixing ratio of component A to component B is 3% (w/w), 6% (w/w), 12% (w/w), or 24% (w/w). 3. The method of claim 2, wherein the mixing ratio of component A to component B is 3% (w/w). 4. The method of claim 3, wherein the pancreatic tissue is porcine pancreas. 5. The method of claim 3, wherein the pancreatic tissue is human pancreas. 6. The method of claim 2, wherein the mixing ratio of component A to component B is 6% (w/w). 7. The method of claim 6, wherein the pancreatic tissue is porcine pancreas. 8. The method of claim 6, wherein the pancreatic tissue is human pancreas. 9. The method of claim 2, wherein the mixing ratio of component A to component B is 12% (w/w). 10. The method of claim 9, wherein the pancreatic tissue is porcine pancreas. 11. The method of claim 9, wherein the pancreatic tissue is human pancreas. 12. The method of claim 2, wherein the mixing ratio of component A to component B is 24% (w/w). 13. The method of claim 12, wherein the pancreatic tissue is porcine pancreas. 14. The method of claim 12, wherein the pancreatic tissue is human pancreas. 15. The method of claim 2, wherein the pancreatic tissue is porcine pancreas. 16. The method of claim 2, wherein the pancreatic tissue is human pancreas. 17. The method of claim 1, wherein the pancreatic tissue has been previously stored using a two-layer method with perfluoro hydrocarbons. 18. The method of claim 1, wherein the pancreatic tissue is porcine pancreas or human pancreas. 19. The method of claim 18, wherein the pancreatic tissue is porcine pancreas. 20. The method of claim 18, wherein the pancreatic tissue is human pancreas.

Details for Patent 8,765,471

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Smith & Nephew, Inc.	SANTYL	collagenase	Ointment	101995	06/04/1965		2023-07-09